Interruption of Dual Antiplatelet Therapy Within Six Months After Coronary Stents (from the Dual Antiplatelet Therapy Study)-Reference-Cited by-同舟云学术

Interruption of Dual Antiplatelet Therapy Within Six Months After Coronary Stents (from the Dual Antiplatelet Therapy Study)

Published:2019-12 Issue:12 Volume:124 Page:1813-1820
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Stefanescu Schmidt Ada C.,Steg Philippe Gabriel,Yeh Robert W.,Kereiakes Dean J.,Tanguay Jean-Francois,Hsieh Wen-Hua,Massaro Joseph M.,Mauri Laura,Cutlip Donald E.

Funder

U.S. Department of Health and Human Services

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents;Mauri;N Engl J Med,2014

2. Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention;Yeh;JAMA,2016

3. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials;Costa;Lancet,2017

4. Duration of antiplatelet therapy after DES implantation: can we trust non-inferiority open-label trials?;Steg;Eur Heart J,2017

5. A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal aafety and efficacy of 3-month dual antiplatelet therapy following endeavor zotarolimus-eluting stent implantation);Kim;J Am Coll Cardiol,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐Term Outcomes and Duration of Dual Antiplatelet Therapy After Coronary Intervention With Second‐Generation Drug‐Eluting Stents: The Veterans Affairs Extended DAPT Study;Journal of the American Heart Association;2023-01-17

2. Thrombotic vs. Bleeding Events of Interruption of Dual Antiplatelet Therapy within 12 Months among Patients with Stent-Driven High Ischemic Risk Definition following PCI;Journal of Interventional Cardiology;2022-01-13

3. Association Between Radial Versus Femoral Access for Percutaneous Coronary Intervention and Long‐Term Mortality;Journal of the American Heart Association;2021-08-03

4. Premature Discontinuation of Dual Antiplatelet Therapy After Coronary Stenting in Veterans: Characteristics and Long‐Term Outcomes;Journal of the American Heart Association;2021-04-26